Skip to content
WeighLab

Next Vial vs ReadyRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Next Vial

Provider comparison

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Semaglutide / month
$199/moMonth-to-month, all doses, compounded
Tirzepatide / month
$249/moMonth-to-month, all doses, compounded
Index 76/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Next Vial pricing Read review

ReadyRx

Provider comparison

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Semaglutide / month
$249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month
$315/moStanding one-month compounded plan; $295 first month with current public offer
Index 76/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check ReadyRx pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 76/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Next Vial
49 states
ReadyRx
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Next Vial

ReadyRx

Semaglutide / month
Next Vial: $199/moMonth-to-month, all doses, compounded
ReadyRx: $249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month
Next Vial: $249/moMonth-to-month, all doses, compounded
ReadyRx: $315/moStanding one-month compounded plan; $295 first month with current public offer
Semaglutide / year (modeled)
Next Vial: $2,388
ReadyRx: $2,988
Tirzepatide / year (modeled)
Next Vial: $2,988
ReadyRx: $3,780
State availability
Next Vial: 49 states
ReadyRx: All 50 states
Oral / sublingual option listed
Next Vial: Not listed
ReadyRx: Not listed
Brand-name access listed
Next Vial: Not confirmed
ReadyRx: Yes
Provider facts checked
Next Vial: October 2026
ReadyRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Next Vial

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Reasons to consider it

  • Names Manifest Pharmacy as a dispensing partner
  • Displays a LegitScript verification link
  • Publishes a 49-state coverage list, excluding Alaska

What to weigh up

  • The lowest advertised monthly equivalents require paying for a longer supply up front
  • The page headline differs from the actual plan selector, so use the selected plan total
  • No individual medical director is named

Compounded drugs are not FDA-approved. Understand the medication options.

Check Next Vial pricing Read the full Next Vial review

ReadyRx

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Reasons to consider it

  • Current one-month renewal rates are $249 semaglutide and $315 tirzepatide
  • The public price calculator separates first-month discounts from renewal prices
  • Provider messaging, shipping, protocols, meal plans and coaching are included

What to weigh up

  • Headline first-month offers are lower than the recurring price
  • The lower $179 semaglutide first-month offer is calculated for the quarterly plan
  • Cancel at least four business days before renewal; shipments can be processed early

Compounded drugs are not FDA-approved. Understand the medication options.

Check ReadyRx pricing Read the full ReadyRx review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Next VialReadyRx
Normalized Cost/Month
Next Vial:
68/100
ReadyRx:
61/100
Price Transparency
Next Vial:
97/100
ReadyRx:
94/100
Nationwide Access
Next Vial:
78/100
ReadyRx:
86/100
Formulation Options
Next Vial:
66/100
ReadyRx:
79/100
Clinical Oversight
Next Vial:
82/100
ReadyRx:
79/100
Contract Flexibility
Next Vial:
55/100
ReadyRx:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Next VialAlternatives to ReadyRx
More provider matchups
CoreAge Rx vs Next VialCoreAge Rx vs ReadyRx
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.